
“23andMe Inc., the Google Inc.-backed DNA analysis company co-founded by Anne Wojcicki, was told by U.S. regulators to halt sales of its main product because it’s being sold without ‘marketing clearance or approval.’ The Saliva Collection Kit and Personal Genome Service, or PGS, tells users whether they carry a disease, are at risk of a disease and would respond to a drug. Most of the uses fall into the category of a medical device and require Food and Drug Administration approval, the agency told the Mountain View, California-based company in a Nov. 22 letter made public today.”
Related posts:
Thai airport officials linked to rhino poaching
UN: Human rights abuses increase in Iran in 2012
Mongolia at a crossroad as boom brings challenges
China's Currency Could Appreciate 500% In Next Three Decades, Investor Jim Rogers Says
Jury Nullifies Felony in Cannabis Grower’s Trial
NSA spying allegations mean U.S. could provide ‘virtually unlimited’ info on citizens to allies
Not All Insurers Game for State Exchanges: The Consumer Impact
The hidden dangers of legal highs
Sexual predator investigator probed for sex with teenage boy
California Police Kill Again, Hit Restrained Man In The Head At Least 10 Times With A Baton
Bitcoin Startup Investments Surpass $117 Million
New UK Bitcoin exchange to bar US clients
Vietnam jails 22 activists for subversion
SF Police shut down chess games on Market Street
Marc Faber: Odds of Global Recession Are 100%